Lab-on-Chip Market

A lab-on-chip is a miniaturized device that integrates multiple laboratory analyses techniques onto a single chip. Different laboratory analysis techniques such as biochemical detection, DNA sequencing, PCR, and others can be seamlessly integrated through lab-on-chip technology. Different advantages associated with this technology include parallelization, high assay sensitivity, ergonomy, waste minimization, and others. The chip used for this technology can be up to a maximum of a few square centimeters in size and can handle extremely small fluid volumes, as low as pico liters. The lab-on-chip market is anticipated to experience significant growth in the near future.

Rise in adoption of personalized medicine, increase in drug discovery and life science research, and the need for high speed diagnostics are the factors that drive the growth of the lab on chip industry. However, limited technological knowledge and availability of alternative technologies are anticipated to restrict the market growth. Moreover, the increase in R&D investments in developing economies is expected to provide lucrative opportunities for key market players throughout the forecast period.

The global lab-on-chip market trends are analyzed through different verticals in the report. Based on product, the market is segmented into the following sub-segments, namely, reagents & consumables, instruments, and software & services. The instruments and reagents & consumables segments are anticipated to experience rapid growth in the near future owing to the surge in demand for lab-on-chip technology in both the developed and the emerging markets. Similarly, by technology, the lab-on-chip market size is analyzed through different technologies such as microarray, microfluidics, and tissue biochip.

Furthermore, the market share is analyzed based on application into genomics & proteomics, diagnostics, and others. The end user analysis captures the lab-on-chip market size with respect to different end users such as hospitals & clinics, diagnostic centers, academic & research institutes and others

The report also covers different key strategic developments such as product development, acquisition, agreement, collaboration, and others undertaken by key players to improve their market position in the industry. Furthermore, technological advancements in the global lab-on-chip industry are also considered in the analysis. For instance, in February 2019, Biomillenia, a France based life-science company launched its launch of its microbiome culture collection service to identify previously uncultured bacteria. This service is based on the company’s proprietary microbiome-on-a-chip technology platform. Similarly, it has been estimated that along with the significant players such as Abbott Laboratories and EMD Millipore, other players such as Biomillenia are also anticipated to gain the lab on chip market share during the forecast period.

The lab on chip market is also expected to benefit significantly through different research endeavors undertaken by researchers. For example, in April 2019, researchers from the Princeton University (U.S.) developed a new technology, which is projected to replace laboratory settings with a single microchip. This technology used complex biosensors systems as its principle and employs tiny metal layers embedded in a microchip to eliminate the bulky & complex optical instrumentation used in the diagnostic laboratories. Similarly, researchers from other universities are also constructively working on lab on chip technology. For instance, in February 2016, researchers at the University of Kansas (U.S.) developed a new lab-on-a-chip diagnostic device that will regulate the liquid biopsy principle to quickly detect cancer using a droplet of plasma or blood.

Comprehensive competitive analysis and profiles of major market players, such as EMD Millipore, Thermo Fisher Scientific, Inc., Abbott Laboratories, Roche Diagnostics, uFluidix, Bio-Rad Laboratories, CellBio, Inc., Achira Labs, Illumina, Inc., and Agilent Technologies, are also provided in this report.

Key Benefits:

• The report provides an extensive analysis of the current market trends and future estimations of the global lab-on-chip market.
• The global lab-on-chip market top player positioning is comprehensively analyzed in the report.
• The lab-on-chip market share is comprehensively analyzed with respect to the product, technology, application and end user.
• The report also analyzes the market growth through different macro indicators and micro indicators.
• Key manufacturers involved in the market are listed and analyzed in this report to understand the competitive scenario of the market.

Key Segments:

By Product

• Reagents & Consumables
• Instruments
• Software & Services

By Technology

• Microarray
• Microfluidics
• Tissue Biochip

By Application

• Genomics & Proteomics
• Diagnostics
• Others

By End User

• Hospitals & Clinics
• Diagnostic Centers
• Academic & Research Institutes
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

 Lab-on-Chip Market Report Highlights